Literature DB >> 3339712

Delineation of the viral products of recombination in vaccinia virus-infected cells.

D D Spyropoulos1, B E Roberts, D L Panicali, L K Cohen.   

Abstract

Plasmids containing the vaccinia virus thymidine kinase gene, its flanking DNA sequences, and the Escherichia coli beta-galactosidase gene were used in conjunction with a thymidine kinase-deficient virus to examine the viral products of recombination. Progeny derived from single-crossover events could be distinguished from those generated by gene conversion or double-crossover events when the beta-galactosidase gene was separated from the thymidine kinase gene by the flanking sequences. Using methotrexate to select for recombinant virus and a chromogenic indicator to detect beta-galactosidase, the generation of viral recombinants was measured over a 48-h period. Recombinant progeny were first observed at 12 h and increased to a maximum of 2.5% at 48 h. Single-crossover products, as determined by beta-galactosidase expression, reached a maximum of 57% of the recombinant population at 24 h and thereafter declined. DNA hybridization analysis was used to examine genomic structures of the progeny of the initial viral plaques, plaques purified three times, and those subject to a 10(4)-fold amplification. These analyses confirmed that single-crossover events within either the 5'- or 3'-homologous flanking sequences generated unstable recombinant structures. These structures were shown to contain a single copy of the intact thymidine kinase gene within the corresponding copy of the duplicated thymidine kinase flanking sequences, separated by the beta-galactosidase gene and plasmid DNA. Significantly, these duplicated structures could undergo further recombination to produce repeats of either the intact or the deleted thymidine kinase sequences. These intermediate structures ultimately degenerated to produce either the parental thymidine kinase-deleted or the wild-type genome. The wild-type genome was also shown to be generated directly by gene conversion or double-crossover events.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3339712      PMCID: PMC253665     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  [Genetic studies with mammalian poxviruses. I. Demonstration of recombination between two strains of vaccina virus].

Authors:  F FENNER; B M COMBEN
Journal:  Virology       Date:  1958-06       Impact factor: 3.616

2.  Non-producer human cells induced by murine sarcoma virus.

Authors:  J S Rhim; H Y Cho; R J Huebner
Journal:  Int J Cancer       Date:  1975-01-15       Impact factor: 7.396

3.  Sequence-nonspecific replication of transfected plasmid DNA in poxvirus-infected cells.

Authors:  A M DeLange; G McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

4.  Replacement of chromosome segments with altered DNA sequences constructed in vitro.

Authors:  S Scherer; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

5.  Virus type-specific thymidine kinase in cells biochemically transformed by herpes simplex virus types 1 and 2.

Authors:  D B Davis; W Munyon; R Buchsbaum; R Chawda
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

6.  High-frequency homologous recombination in vaccinia virus DNA.

Authors:  L A Ball
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

7.  Marker rescue of temperature-sensitive mutations of vaccinia virus WR: correlation of genetic and physical maps.

Authors:  M J Ensinger; M Rovinsky
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

8.  Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus.

Authors:  R C Condit; A Motyczka; G Spizz
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

9.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

10.  Vaccinia virus: a selectable eukaryotic cloning and expression vector.

Authors:  M Mackett; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

View more
  23 in total

1.  Effects of DNA structure and homology length on vaccinia virus recombination.

Authors:  X D Yao; D H Evans
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  High-frequency genetic recombination and reactivation of orthopoxviruses from DNA fragments transfected into leporipoxvirus-infected cells.

Authors:  Xiao-Dan Yao; David H Evans
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

3.  Generation of hybrid genes and proteins by vaccinia virus-mediated recombination: application to human immunodeficiency virus type 1 env.

Authors:  L Gritz; A Destree; N Cormier; E Day; V Stallard; T Caiazzo; G Mazzara; D Panicali
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

4.  Heteroduplex DNA formation is associated with replication and recombination in poxvirus-infected cells.

Authors:  C Fisher; R J Parks; M L Lauzon; D H Evans
Journal:  Genetics       Date:  1991-09       Impact factor: 4.562

5.  In vitro resolution of poxvirus replicative intermediates into linear minichromosomes with hairpin termini by a virally induced Holliday junction endonuclease.

Authors:  D Stuart; K Ellison; K Graham; G McFadden
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

6.  Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.

Authors:  R Blasco; B Moss
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Utilization of DNA recombination for the two-step replacement of growth factor sequences in the vaccinia virus genome.

Authors:  D D Spyropoulos; V Stallard; B E Roberts; L K Cohen
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

8.  Two types of deletions in orthopoxvirus genomes.

Authors:  S N Shchelkunov; A V Totmenin
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

9.  Effect of marker distance and orientation on recombinant formation in poxvirus-infected cells.

Authors:  R J Parks; D H Evans
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones.

Authors:  R A Littaua; A Takeda; J Cruz; F A Ennis
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.